Last Round
Seed
Jul 6, 2023
Total Funding Raised
$8.49M
Company Overview
Imophoron is a biotechnology company developing a novel, next-generation nanoparticle platform, ADDomer™, for the development of vaccines to combat infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imophoron Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Imophoron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 6, 2023 | ||||
| Seed | Oct 7, 2021 | ||||
| Grant | Dec 1, 2017 |
Imophoron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Brain Corporation | Seed |
| Science Creates Ventures | Seed |
| Octopus Investments | Seed |
| Biotechnology and Biological Sciences Research Council | Grant |
| Octopus Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2023
Raised $3.05M from Octopus Investments, Global Brain, and Science Creates.
Imophoron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imophoron's valuation, stock price, and market status.